Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06048640 · ClinicalTrials.gov registry record · NA

Effects of Dynamine Ingestion on Various Indices of Sustained Energy

A NA study of Energy, sponsored by The Center for Applied Health Sciences.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06048640 is a NA study of Energy that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 25 participants, below the 861-participant average among 7 other Energy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06048640, a NA study of Energy, has completed, sponsored by The Center for Applied Health Sciences.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, placebo-controlled, double-blind, within-subject crossover trial of 25 men and women. The objective of this study is to assess the effects of Dynamine (methylliberine) supplementation on overall well-being including energy, sustained energy, mental stamina, focus, concentration, motivation to accomplish difficult tasks, drive, vigor, positive outlook, maintaining a healthy mood, feelings of well-being, and resilience to stress.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Dynamine (methylliberine)

Study Locations (1)

Ohio

  • The Center for Applied Health Sciences - Canfield

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-09-30
Est. Completion 2023-07-21
Phase NA

What the Registry Record Tells You About NCT06048640

The ClinicalTrials.gov registry entry for NCT06048640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 861-participant average among 7 other Energy trials with a reported enrollment target (97% lower). The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Energy appearing as the primary indexed condition, and to 1 intervention - of which Dynamine (methylliberine) is the first listed.

NCT06048640 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06048640 about?

NCT06048640 is a clinical study titled "Effects of Dynamine Ingestion on Various Indices of Sustained Energy". This study is a randomized, placebo-controlled, double-blind, within-subject crossover trial of 25 men and women. The objective of this study is to assess the effects of Dynamine (methylliberine) supplementation on overall well-being including energy, sustained energy, mental stamina, focus, concent...

What is the current status of trial NCT06048640?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-09-30. Estimated completion is 2023-07-21.

What conditions does trial NCT06048640 study?

This clinical trial studies the following conditions: Energy.

What interventions are being tested in trial NCT06048640?

The interventions under investigation include: Dynamine (methylliberine) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06048640?

This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06048640 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Energy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.